| TO: | DDS Regional Directors, STS Director, CTH Coordinators, Private Providers, CO Quality Management Personnel |
| FROM: | Daniel A. Micari, Director, Quality Management Services |
| DATE: | December 7, 2010 |
| RE: |
MEDICATION RECALL ADVISORY: Recall of Mylanta and Alternagel Liquid Products |
Medication Recall Advisory
MEDICATION Recall Advisory November 29, 2010:
On November 29, 2010, in consultation with the U.S. Food and Drug Administration (FDA), Johnson & Johnson-Merck Consumer Pharmaceuticals, Co. (JJMCP) recalled, from the wholesale and retail level, twelve MYLANTA® liquid products and one AlternaGEL® liquid product. JJMCP is conducting the recall in order to update the labeling for these products. The specific products involved are being recalled in the United States and Puerto Rico.
JJMCP initiated the recall after an internal review revealed that information about the presence of alcohol from flavoring agents was not noted on the packaging.
For further information, please view the below website:
http://www.fda.gov/Safety/Recalls/ucm235376.htm
For further information, please view the below website:
http://www.fda.gov/Safety/Recalls/ucm235376.htm
Please ensure those responsible are aware of this food medication recall advisory. Also review your medication supplies to determine whether or not the identified products are present. If the identified products are present, address appropriately.